Innovasis Submits OpteryX(TM) Cervical Plate System For FDA Clearance

Published: Jun 05, 2006

SALT LAKE CITY, June 5 /PRNewswire/ -- Utah-based spinal implant company Innovasis recently submitted its new Cervical Plate System to the FDA for 510(k) clearance. The Innovasis OpteryX(TM) is a cervical plate with a self-locking mechanism with features and benefits that includes: No-step locking, 1 to 4 level plates, and apertures for easy graft visualization with variable, fixed and self-tapping screws.

FDA 510(k) clearance for the OpteryX(TM) Anterior Cervical Plate System is expected in the second half of 2006, according to Martin Crous, Ph.D. vice president of sales and marketing.

Spinal implants are aimed at restoring mechanical and neurological function by readjusting vertebral positioning until bone fusion occurs. Innovasis offers spinal product implants and instruments that address major pathologies and focus areas of traditional spinal surgery, including deformities, degenerative conditions; trauma and tumors, all of which can result in severe back pain and sometimes paralysis. Founded in 2002, Innovasis is committed to providing surgeons with training, support and excellent customer service, thus ensuring the establishment of a strong and long term strategic partnership.

For information on Innovasis contact Martin Crous, Ph.D. at 801-261-2242 or or visit the website at


CONTACT: Martin Crous, Ph.D. of Innovasis, +1-801-261-2242,

Back to news